IL-33 supplementation fails to prevent trTreg reduction in established <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

(S)-(-)-blebbistatin O-benzoate reduces mast cell infiltration in AD-like lesions of NC/Nga mice. by Shunya Sahara (836432)

“…(S)-(-)-blebbistatin O-benzoate treatment significantly decreased mast cell numbers. Data represent mean ± SE, *<i>p</i> < 0.05 vs. vehicle.…”

FAT1 controls degradation of YAP and TAZ proteins in MDA-MB-231 and U-87 cells. by Rui Li (4631)

FAT1 controls degradation of YAP and TAZ proteins in HN13 and CAL27 cells. by Rui Li (4631)

FAT1 controls degradation of YAP and TAZ proteins. by Rui Li (4631)

MF induced EGFR interaction. by Xia Wu (203682)

“…C: The DEP FI decrease percentages in EGFR monomer solution with pretreatment of PD of a serial of concentration. …”

TEC functional assays after hypoxia or Tac. by Vincenzo Cantaluppi (92814)

Effect of thalidomide on CUL5 and NEDD8 localization in HUVEC. by Bryan Kunkler (5204327)

PAMAM-DEN^CYS induces trafficking of ΔF508-CFTR to plasma membrane in CF cells. by Scott Mackenzie Brockman (4433614)

“…Data represent mean ± SEM of triplicate samples. (F) Immunofluorescence microscopy of HEK-293 cells transfected with ΔF508-CFTR and treated with PAMAM-DEN^CYS (500μM, 12 hrs) show increased plasma membrane (PM, yellow arrows) trafficking of CFTR with decreased peri-nuclear aggresome-bodies (AB, red arrows) as compared to controls. …”

Quantitative structure–toxicity relationship models for predication of toxicity of ionic liquids toward leukemia rat cell line IPC-81 based on index of ideality of correlation by Shahin Ahmadi (9334861)

“…The outliers and promoters of increase/decrease of logEC₅₀ are extracted and the mechanistic interpretation of effective descriptors for the model is also offered.Highlights</p><p>Global SMILES-based QSAR model was developed to predict the toxicity of ILs.…”

Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors - Fi... by Vincenzo Cantaluppi (92814)

Regulation of YAP/TAZ through MIB2 in HNSCCs. by Rui Li (4631)

Distributions of genomic features across multiple colorectal cancer and tuberculosis studies. by Yilin Gao (4335571)

Workflow for integrating multiple simulated heterogeneous metagenomic datasets. by Yilin Gao (4335571)

Discovery of Novel Substituted <i>N</i>‑(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors by Jimin Xu (2208961)

“…The preliminary mechanistic studies indicated that compounds <b>6</b> and <b>43</b> possibly target the HAdV DNA replication process, while compounds <b>46</b> and <b>47</b> suppress later steps of HAdV life cycle. Notably, among these derivatives, compound <b>15</b> showed improved anti-HAdV activity (IC₅₀ = 0.27 μM), significantly decreased cytotoxicity (CC₅₀ = 156.8 μM), and low <i>in vivo</i> toxicity (maximum tolerated dose = 150 mg/kg in hamster) as compared with niclosamide, supporting its further <i>in vivo</i> efficacy studies for the treatment of HAdV infections.…”

Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury by Jiahui Cheng (6056966)

Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury by Jiahui Cheng (6056966)

Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury by Jiahui Cheng (6056966)

IFN-γ limits trTreg expansion both <i>in vitro</i> after IL-33 stimulation and <i>in vivo</i> during <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

outcome of HPDL-MIAIHD technique with recent methods [11–12]. by Naif Almakayeel (16846021)